$4M Grant Will Help Advance Research into NVP015 Treatment for Genetic Mitochondrial Disease
News
The U.S. Department of Defense (DoD) has awarded a $4 million, three-year grant to the Children’s Hospital of Philadelphia (CHOP) to advance NeuroVive Pharmaceutical AB‘s NVP015 program for genetic ... Read more